Alzheimer’s Discovery
One in twenty people over sixty-five get Alzheimer’s.Now a team of researchers lead by Dr. Todd Golde of the Mayo Clinic in Jacksonville have found chemicals called gamma-secretase modulators (GSMs) that inhibit the “plaques” of clumps of protein that inhibit brain functions. The GSMs cuts the production of one protein fragment that builds up. San Diego clinical trials
Except where expressly acknowledged, this work is distributed and licensed to you under the terms of this license. For other licenses, contact news.





























